P388
Cross-source identity
Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats P388 as ChEMBL target CHEMBL389. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Why P388 matters
P388 is reviewed as P388; the current evidence base includes 31 approved drugs, 9798 compounds, and 4875 assays, with lead potency reaching pChEMBL 10.9.
P388
Review this target as P388.
Protein source · UniProt accession via ChEMBL component mappingDisease relevance is not yet populated for this evidence card.
This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
ChEMBL target recordChEMBL currently tracks 31 approved drugs, 9798 compounds, and 4875 assays for this target. The dominant activity type is IC50. CHEMBL256099 is the current potency anchor at pChEMBL 10.9.
Use CHEMBL256099 as the tractability anchor when discussing potency (pChEMBL 10.9).
Activity source · ChEMBL 36 via Core EngineStart with the right source
Pick the first block or linked source that matches the review question in front of you.
Start with the review rationale when you need to explain why P388 matters before drilling into raw source blocks.
Jump to Review RationaleGo back to the target snapshot when you need the naming and mapping contract, not just the summarized rationale.
Open Protein ContextUse the target snapshot disease block when you need the disease program and supporting signals, not only the card summary.
Open Disease ContextSnapshot State
No project snapshot selected. Export uses the live evidence card state.
pChEMBL Activity Distribution
Top 5 Inhibitors (by pChEMBL)
| Structure | Compound | pChEMBL | Type | Phase |
|---|---|---|---|---|
|
|
No preferred name
CHEMBL256099
|
10.9 | IC50 | — |
|
|
No preferred name
CHEMBL274951
|
10.7 | IC50 | — |
|
|
No preferred name
CHEMBL255716
|
10.7 | IC50 | — |
|
|
No preferred name
CHEMBL256302
|
10.5 | IC50 | — |
|
|
No preferred name
CHEMBL1797231
|
10.5 | IC50 | — |
Approved Drugs
| Structure | Compound | First Approval |
|---|---|---|
|
|
PLITIDEPSIN
CHEMBL451930
|
2018 |
|
|
TOPOTECAN
CHEMBL84
|
1996 |
|
|
DOCETAXEL
CHEMBL3545252
|
1995 |
|
|
TRIMETREXATE
CHEMBL119
|
1993 |
|
|
PACLITAXEL
CHEMBL428647
|
1992 |
|
|
PODOFILOX
CHEMBL61
|
1990 |
|
|
MITOXANTRONE
CHEMBL58
|
1987 |
|
|
AMSACRINE
CHEMBL43
|
1987 |
|
|
ETOPOSIDE
CHEMBL44657
|
1983 |
|
|
MITOMYCIN
CHEMBL105
|
1981 |
|
|
DAUNORUBICIN HYDROCHLORIDE
CHEMBL1563
|
1979 |
|
|
DAUNORUBICIN
CHEMBL178
|
1979 |
|
|
DOXORUBICIN
CHEMBL53463
|
1974 |
|
|
DOXORUBICIN HYDROCHLORIDE
CHEMBL359744
|
1974 |
|
|
PLICAMYCIN
CHEMBL1237054
|
1970 |
|
|
CYTARABINE
CHEMBL803
|
1969 |
|
|
THIOGUANINE
CHEMBL727
|
1966 |
|
|
VINBLASTINE
CHEMBL159
|
1965 |
|
|
DACTINOMYCIN
CHEMBL1554
|
1964 |
|
|
MELPHALAN
CHEMBL852
|
1964 |
|
|
VINCRISTINE
CHEMBL90555
|
1963 |
|
|
FLUOROURACIL
CHEMBL185
|
1962 |
|
|
COLCHICINE
CHEMBL107
|
1961 |
|
|
METHOTREXATE
CHEMBL34259
|
1953 |
|
|
EMETINE
CHEMBL50588
|
— |